Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | Director | July 15, 2026 | July 18, 2026 |
| Pulmonx CorpLUNG · Entity 2359 | Director | June 05, 2026 | June 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date July 15, 2026 · Filed July 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,329 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 344 · Balance 8,329 F1: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.
Pulmonx Corp
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 139,714 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 40,000 · Balance 139,714 F1: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 18, 2026 01:28 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 344 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-084767 · tm2620811-4_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,329 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:56 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001817552-26-000002 · form4-06092026_090601.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,714 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. Read SEC document |
| May 01, 2026 Filed May 4, 2026 22:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 50 | $56.70 | $2,835.00 |
DisclosureSEC source: 0001104659-26-055057 · tm2613528-1_4seq1.xml · nonDerivative · entry 2 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,985 F2 · shares: Represents the number of shares of common stock withheld by Inspire Medical Systems, Inc. to cover the Reporting Person's tax withholding obligation upon the vesting of RSUs granted on May 1, 2025. Read SEC document |
| April 30, 2026 Filed May 4, 2026 22:18 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 3,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-055057 · tm2613528-1_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,035 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 307 | $52.07 | $15,985.49 |
DisclosureSEC source: 0001104659-26-044368 · tm2612028-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,473 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:06 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 180 | $96.47 | $17,364.60 |
DisclosureSEC source: 0001104659-26-005032 · tm263634-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,166 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| October 14, 2025 Filed Oct 16, 2025 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 229 | $78.84 | $18,054.36 |
DisclosureSEC source: 0001104659-25-100096 · tm2528856-4_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,986 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| July 15, 2025 Filed Jul 16, 2025 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 131 | $128.00 | $16,768.00 |
DisclosureSEC source: 0001104659-25-068325 · tm2521079-1_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,757 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:07 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 37,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015644 · form4-06042025_100657.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,714 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 2, 2025, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. Read SEC document |
| May 02, 2025 Filed May 5, 2025 23:27 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 35 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-044670 · tm2514079-4_4seq1.xml · nonDerivative · entry 2 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,626 F2 · shares: Represents the number of shares of common stock withheld by Inspire Medical Systems, Inc. to cover the Reporting Person's tax withholding obligation upon the vesting of RSUs granted on May 2, 2024. Read SEC document |
| May 01, 2025 Filed May 5, 2025 23:27 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 1,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-044670 · tm2514079-4_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,661 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 14, 2025 Filed Apr 16, 2025 20:06 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 102 | $149.70 | $15,269.40 |
DisclosureSEC source: 0001104659-25-035495 · tm2512484-2_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,395 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 01:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 80 | $176.33 | $14,106.40 |
DisclosureSEC source: 0001104659-25-004601 · tm253739-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,293 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 20:22 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 79 | $210.46 | $16,626.34 |
DisclosureSEC source: 0001104659-24-109198 · tm2426283-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,213 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 21:08 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 32 | $138.58 | $4,434.56 |
DisclosureSEC source: 0001104659-24-080586 · tm2419668-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,134 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:49 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 15,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015623 · form4-06052024_090612.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,561 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 3, 2024, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. Read SEC document |
| May 02, 2024 Filed May 6, 2024 22:11 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 716 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-057566 · tm2413647-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,102 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 12, 2024 Filed Apr 16, 2024 21:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 56 | $231.74 | $12,977.44 |
DisclosureSEC source: 0001104659-24-047881 · tm2411955-2_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,386 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 01:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 80 | $186.10 | $14,888.00 |
DisclosureSEC source: 0001104659-24-004911 · tm243653-6_4seq1.xml · nonDerivative · entry 3 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,330 F3 · shares: Represents shares of Common Stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 01:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 8 | $150.47 | $1,203.76 |
DisclosureSEC source: 0001104659-24-004911 · tm243653-6_4seq1.xml · nonDerivative · entry 2 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250 F2 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error. Read SEC document |
| January 16, 2024 Filed Jan 19, 2024 01:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2 | $325.91 | $651.82 |
DisclosureSEC source: 0001104659-24-004911 · tm243653-6_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,242 F1 · shares: Represents shares of Common Stock issued in lieu of cash fees as to which the Reporting Person is entitled pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023. Such shares were not previously issued due to an inadvertent clerical error. Read SEC document |
| October 13, 2023 Filed Oct 17, 2023 23:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 91 | $150.47 | $13,692.77 |
DisclosureSEC source: 0001104659-23-109694 · tm2328548-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,240 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 42 | $325.91 | $13,688.22 |
DisclosureSEC source: 0001104659-23-082375 · tm2321602-4_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,149 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:45 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 12,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-034006 · doc4.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,345 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2023, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. Read SEC document |
| April 27, 2023 Filed May 1, 2023 23:47 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-054644 · tm2314266-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,107 F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:07 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 59 | $231.77 | $13,674.43 |
DisclosureSEC source: 0001104659-23-044577 · tm2312581-4_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 438 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 10, 2023 Filed Jan 20, 2023 00:56 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 55 | $248.31 | $13,657.05 |
DisclosureSEC source: 0001104659-23-005114 · tm233800-4_4.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| October 11, 2022 Filed Oct 13, 2022 20:23 UTC | Inspire Medical Systems, Inc. [INSP · Entity 1186 | GrantCommon Stock | 81 | $168.98 | $13,687.38 |
DisclosureSEC source: 0001104659-22-108505 · tm2228171-5_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 22:12 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 70 | $193.86 | $13,570.20 |
DisclosureSEC source: 0001104659-22-079612 · tm2221003-5_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:16 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034324 · doc4.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,725 F1 · shares: Represents grant of Restricted Stock Units ("RSU Grant") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2022, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made. Read SEC document |
| April 28, 2022 Filed May 11, 2022 00:51 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantStock Option (right to buy) · Derivative | 1,243 | $0.00 Strike: $211.29 | $0.00 |
DisclosureSEC source: 0001104659-22-058422 · tm2215111-7_4seq1.xml · derivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,243 Underlying: Common Stock · 1,243 shares Expires 2032-04-28 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 28, 2023, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 08, 2022 Filed Apr 13, 2022 00:47 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 54 | $254.08 | $13,720.32 |
DisclosureSEC source: 0001104659-22-045211 · tm2212578-5_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 21:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 60 | $227.56 | $13,653.60 |
DisclosureSEC source: 0001104659-22-003601 · tm222681-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| October 08, 2021 Filed Oct 13, 2021 20:49 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 59 | $231.04 | $13,631.36 |
DisclosureSEC source: 0001104659-21-125835 · tm2129887-4_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:09 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 426 | $0.00 Strike: $93.14 | $0.00 |
DisclosureSEC source: 0001104659-21-109031 · tm2125754-1_4seq1.xml · derivative · entry 4 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,556 Underlying: Common Stock · 426 shares Expires 2030-07-08 F1 · derivative.exercise_date: The original 3,834 shares underlying the option have vested or will vest and become exercisable in three equal annual installments that began on July 8, 2021, subject to the Non-Employee Director continuing in service through each applicable vesting date. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:09 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 140 | $212.00 | $29,680.00 |
DisclosureSEC source: 0001104659-21-109031 · tm2125754-1_4seq1.xml · nonDerivative · entry 3 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:09 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 426 | $212.29 | $90,435.54 |
DisclosureSEC source: 0001104659-21-109031 · tm2125754-1_4seq1.xml · nonDerivative · entry 2 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140 Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:09 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 426 | $93.14 | $39,677.64 |
DisclosureSEC source: 0001104659-21-109031 · tm2125754-1_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 140 | $206.97 | $28,975.80 |
DisclosureSEC source: 0001104659-21-108154 · tm2125596-1_4seq1.xml · nonDerivative · entry 3 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140 Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 852 | $0.00 Strike: $93.14 | $0.00 |
DisclosureSEC source: 0001104659-21-108154 · tm2125596-1_4seq1.xml · derivative · entry 4 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,982 Underlying: Common Stock · 852 shares Expires 2030-07-08 F2 · derivative.exercise_date: The original 3,834 shares underlying the option have vested or will vest and become exercisable in three equal annual installments that began on July 8, 2021, subject to the Non-Employee Director continuing in service through each applicable vesting date. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 852 | $207.08 | $176,432.16 |
DisclosureSEC source: 0001104659-21-108154 · tm2125596-1_4seq1.xml · nonDerivative · entry 2 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.96 to $207.20. The reporting person undertakes to provide the Company, any security holder of Inspire Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Exercise / conversionCommon Stock | 852 | $93.14 | $79,355.28 |
DisclosureSEC source: 0001104659-21-108154 · tm2125596-1_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,132 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:10 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 71 | $185.73 | $13,186.83 |
DisclosureSEC source: 0001104659-21-091745 · tm2122094-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:20 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040074 · doc4.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,810 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021. Read SEC document |
| April 29, 2021 Filed May 3, 2021 21:14 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantStock Option (right to buy) · Derivative | 1,175 | $0.00 Strike: $240.68 | $0.00 |
DisclosureSEC source: 0001104659-21-060313 · tm2114992-4_4seq1.xml · derivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,175 Underlying: Common Stock · 1,175 shares Expires 2031-04-29 F1 · derivative.exercise_date: The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| April 09, 2021 Filed Apr 13, 2021 20:16 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 57 | $218.45 | $12,451.65 |
DisclosureSEC source: 0001104659-21-049764 · tm2112723-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:15 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 64 | $194.10 | $12,422.40 |
DisclosureSEC source: 0001104659-21-003443 · a4.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:17 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 88 | $130.00 | $11,440.00 |
DisclosureSEC source: 0001104659-20-114519 · a4.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 20:16 UTC | Pulmonx Corp LUNG · Entity 2359 | PurchaseCommon Stock | 26,315 | $19.00 | $499,985.00 |
DisclosureSEC source: 0001628280-20-014285 · wf-form4_160192895266858.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,315 Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:12 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001628280-20-014197 · wf-form4_160166952397201.xml · derivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-09-29 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal consecutive monthly installments commencing on September 30, 2020, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.